Qing Li

19.5k total citations · 6 hit papers
533 papers, 13.2k citations indexed

About

Qing Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qing Li has authored 533 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 222 papers in Molecular Biology, 172 papers in Cancer Research and 154 papers in Oncology. Recurrent topics in Qing Li's work include Cancer-related molecular mechanisms research (66 papers), MicroRNA in disease regulation (62 papers) and RNA modifications and cancer (42 papers). Qing Li is often cited by papers focused on Cancer-related molecular mechanisms research (66 papers), MicroRNA in disease regulation (62 papers) and RNA modifications and cancer (42 papers). Qing Li collaborates with scholars based in China, United States and Canada. Qing Li's co-authors include Qing Jing, Yongwen Qin, Guokun Wang, Yue Li, Juntao Zhang, Jia He, Jiaqi Zhu, Richard F. Silver, W. Henry Boom and Hao Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Qing Li

503 papers receiving 13.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans

2010 966 citations Qing Li, Qing Jing et al. profile →
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

2017 413 citations Qing Li et al. profile →
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

2022 178 citations Qing Li et al. profile →
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

2024 169 citations Qing Li, Hao Luo et al. profile →
Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications

2022 149 citations Qing Li et al. profile →
Modified acid polysaccharide derived from Salvia przewalskii with excellent wound healing and enhanced bioactivity

2024 62 citations Qing Li et al. profile →

Peers

Countries citing papers authored by Qing Li

Since Specialization

Citations

This map shows the geographic impact of Qing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Li more than expected).

Fields of papers citing papers by Qing Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Li. The network helps show where Qing Li may publish in the future.

Co-authorship network of co-authors of Qing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Li. A scholar is included among the top collaborators of Qing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Li. Qing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Systemic inflammation biomarkers can identify high tumor mutation burden in lung adenocarcinoma 2025 ·BMC Cancer ·(unknown), Qing Li, (unknown), Xiaojie Yang, Qiongyao Zhang, Yusheng Chen, (unknown)	0
2	Vitamin D and skin disorders: bridging molecular insights to clinical innovations 2025 ·Molecular Medicine ·Qing Li, Hung Chan	3
3	Dihydromyricetin mitigates epilepsy and cognitive impairment via NLRP3 inhibition in rats 2025 ·Folia Neuropathologica ·Qing Li, (unknown), (unknown), (unknown), (unknown), Yange Zhang, (unknown), (unknown), Weiping Wang	0
4	The miR-23a/27a/24 − 2 cluster drives immune evasion and resistance to PD-1/PD-L1 blockade in non-small cell lung cancer 2024 ·Molecular Cancer ·Hao Luo, Bin Hu, (unknown), Jing Chen, (unknown), Wei Zhang, Rentao Wang, (unknown), Wei Guo, Nan Dai, (unknown), Qing Li, Cheng‐Xiong Xu, Hua Jin	11
5	Association of clopidogrel resistance and ABCD-GENE score with long-term clinical prognosis in patients with ischemic stroke or TIA 2024 ·Revue Neurologique ·Yan Kang, Guo Li, Qing Li, (unknown), Wei Jin, Meng Huang, Yun Liu, Chun Tang, Jingci Zhu, Li Zhang	1
6	Iron Oxide Nanoparticles Engineered Macrophage-Derived Exosomes for Targeted Pathological Angiogenesis Therapy 2024 ·ACS Nano ·Haorui Zhang, Yu Mao, Zheng Nie, Qing Li, Mengzhu Wang, Cai Chang, Weiju Hao, Xi Shen, Ning Gu, (unknown), Hongyuan Song	34
7	Lamprey prohibitin 2 inhibits non-small cell lung carcinoma cell proliferation by down-regulating the expression and phosphorylation levels of cell cycle-associated proteins 2023 ·Fish & Shellfish Immunology ·Xue Zhang, (unknown), Qing Li, Di Qin, Wen‐Wei Li, Xinyu Wang, (unknown), Qingwei Li, (unknown)	1
8	SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9‐Mediated GSK3β/β‐Catenin Signaling 2023 ·Advanced Science ·Qing Li, Hao Luo, Fuqiang Dai, Rentao Wang, (unknown), Yuanyuan Luo, Mengsheng Deng, Yulun Wang, Long Tan, Wei Guo, Bo Xu, Cheng‐Xiong Xu, Hua Jin	22
9	A Ketogenic Diet may Improve Cognitive Function in Rats with Temporal Lobe Epilepsy by Regulating Endoplasmic Reticulum Stress and Synaptic Plasticity 2023 ·Molecular Neurobiology ·(unknown), Shuang Tian, (unknown), (unknown), Qing Li, (unknown), Weiping Wang	11
10	Clinical Characteristics and Treatment Outcomes of Testicular Myeloid Sarcomas After Hematopoietic Stem Cell Transplantation: A Single-institution Experience 2021 ·Clinical Genitourinary Cancer ·Yiqing Du, Qing Li, Xiaowei Zhang, Tao Xu	0
11	The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID‐19 in Wuhan, China: A retrospective study 2020 ·Journal of Medical Virology ·(unknown), Yanping Cai, (unknown), Yanping Li, Yong Lin, Qing Li, (unknown), (unknown), (unknown)	15
12	An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients 2020 ·Cellular and Molecular Neurobiology ·(unknown), Qing Li, (unknown), Yimin Huang	44
13	Serum prealbumin predicts prognosis of hepatectomy in patients with hepatocellular carcinoma 2020 ·Zhonghua gan-dan waike zazhi ·Minjun Li, (unknown), Qing Li, (unknown), Rong‐Rui Huo, Liang Ma, Bang‐De Xiang, Le‐Qun Li, Jian‐Hong Zhong	2
14	Transcription Factor SOX18 Promotes Clear Cell Renal Cell Carcinoma Progression and Alleviates Cabozantinib-Mediated Inhibitory Effects 2019 ·Molecular Cancer Therapeutics ·(unknown), Caipeng Qin, Qiang Wang, (unknown), (unknown), (unknown), Xiaowei Zhang, Qing Li, Shijun Liu, Tao Xu	14
15	p300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate Cells 2019 ·Hepatology ·Yuanguo Wang, Kangsheng Tu, Donglian Liu, (unknown), Yun‐Ru Chen, Qing Li, Jessica L. Maiers, Zhikui Liu, Vijay H. Shah, Changwei Dou, Daniel J. Tschumperlin, (unknown), Rendong Yang, Ningling Kang	77
16	Circulating Plasma miRNAs as Potential Biomarkers of Non–Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling 2018 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Ming‐Yang Su, Yike Wu, Liwu Fu, Kang Kang, Qing Li, Li Li, (unknown), Furong Li, Deming Gou	21
17	Two Functional MicroRNA-126s Repress a Novel Target Gene p21-Activated Kinase 1 to Regulate Vascular Integrity in Zebrafish 2010 ·Circulation Research ·Jun Zou, Wenqing Li, Qing Li, Xiangqi Li, Juntao Zhang, Ganqiang Liu, Jian Chen, (unknown), Fu‐Ju Tian, (unknown), Ni Zhu, Yong-wen QIN, Bairong Shen, Ting Xi Liu, Qing Jing	61
18	[Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome]. 2007 ·PubMed ·Xiaomei Li, Xiang-Pei Li, Long Qian, Guosheng Wang, Hong Zhang, (unknown), Qing Li, Ke Chen, Xiaoqiu Wang, Yi‐Ping Wang	5
19	[Clinical characteristics and prognosis of breast cancer patients with vascular invasion]. 2007 ·PubMed ·(unknown), Binghe Xu, Pin Zhang, Qing Li, (unknown), Yan Sun	1
20	Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells, cytotoxic T lymphocytes, natural killer receptors and mRNA transcripts for granzymes and perforin 2005 ·Stress ·Qing Li, Zaifu Liang, Ari Nakadai, Tomoyuki Kawada	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact